Active — Not RecruitingNot Applicable

Prospective Study of Pregnancy in Women With Cystic Fibrosis

United States285 participantsStarted 2021-09-30

Plain-language summary

In this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

Who can participate

Age range16 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant, intending to continue pregnancy, enrolled in the Cystic Fibrosis Foundation Patient Registry (CFFPR) Exclusion Criteria: * None

What they're measuring

Forced expiratory volume at one second (FEV1) percent predicted after delivery and restart of modulators

Timeframe: 42 weeks

Forced expiratory volume at one second (FEV1) percent predicted after delivery

Timeframe: 42 weeks

Trial details

NCT IDNCT04828382

SponsorAmalia Magaret

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-06-30

View on ClinicalTrials.gov More Pregnancy Related trials